Patent directory · USPTO A61K / A61P
Patents matching “Ionis Pharmaceuticals, Inc.”
202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11197884
Modulation of the notch signaling pathway for treatment of respiratory disorders
granted -
US 11193128
Compositions for modulating expression of C9ORF72 antisense transcript
granted -
US 11155815
Compositions and methods for modulating Tau expression
granted -
US 11136577
Methods and compositions for inhibiting PMP22 expression
granted -
US 11129844
Compositions and methods for modulating MECP2 expression
granted -
US 11118183
Modulation of angiopoietin-like 3 expression
granted -
US 11116843
Conjugated antisense compounds and their use
granted -
US 11111494
Compositions for modulating Ataxin 2 expression
granted -
US 11084844
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
granted -
US 11078486
Compounds and methods for reducing ATXN2 expression
granted -
US 11078485
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted -
US 11072794
Compositions and their uses directed to huntingtin
granted -
US 11058709
Methods of treating breast cancer
granted -
US 11033570
Modulation of Lnc05 expression
granted -
US 11021710
Compounds and methods for reducing FXI expression
granted -
US 11000595
Modulators of PCSK9 expression
granted -
US 10961271
Methods of modulating KEAP1
granted -
US 10927377
Modulators of APOL1 expression
granted -
US 10927372
Compositions and methods for modulating apolipoprotein C-III expression
granted -
US 10912792
Compounds and methods for modulating angiotensinogen expression
granted -
US 10907160
Methods for reducing LRRK2 expression
granted -
US 10883104
Compositions and methods for modulating apolipoprotein (a) expression
granted -
US 10858657
Methods for treating hypercholesterolemia
granted -
US 10844379
Conjugated antisense compounds and their use
granted